Can prostate stents be used to predict the outcome of transurethral resection of the prostate in the difficult cases?

Current Opinion in Urology

Volumn 14, Issue 1, 2004, Pages 35-39

  Knutson, Tomas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Benign prostatic hyperplasia; Diagnosis; Overactive bladder; Stent

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; POLYGLYCOLIC ACID; STEROID 5ALPHA REDUCTASE INHIBITOR;

ANALYSIS; BLADDER NECK STENOSIS; DETRUSOR MUSCLE; ENDOPROSTHESIS; HUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE; REVIEW; STENT; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE INCONTINENCE; URINE RETENTION; AGED; BLADDER OBSTRUCTION; FOLLOW UP; HOSPITALIZATION; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROSTATE HYPERTROPHY; PROSTATECTOMY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; URODYNAMICS;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STENTS; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINARY BLADDER NECK OBSTRUCTION; URINARY RETENTION; URODYNAMICS;

EID: 2342588071     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200401000-00008     Document Type: Review

References (40)

1. Madersbacher S, Haidinger G, Temml C, et al. Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2,096 men. Eur Urol 1998; 34:136-141.
2. Abrams P. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology 1994; 44:153-155.
3. Knutson T, Edlund C, Fall M, et al. BPH with coexisting overactive bladder dysfunction - an everyday urological dilemma. Neurourol Urodyn 2001; 20:237-247.
4. Vesely S, Knutson T, Damber J-E, et al. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol 2003; 37:322-328. This nice study described the correlation between age and growth of the prostate, including decrease of flow rates, and increase of prostate-specific antigen. It also described the lack of disease-specific symptoms in BPH.
5. Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate Suppl 1996; 6:67-73.
6. Emberton M, Andriole GL, de la Rosette J, et al. BPH: a progressive disease of the ageing male. Urology 2003; 61:267-273. This is an evidence-based comprehensive review of terminology, natural history and progression of BPH. The review also sets up parameters for identification of progression.
7. Sutherland RS, Baskin LS, Kogan BA, et al. Neuroanatomical changes in the rat bladder after bladder outlet obstruction. Br J Urol 1998; 82:895-901.
8. Tammela T. Benign prostatic hyperplasia. Practical treatment guidelines. Drugs Aging 1997; 10:349-366.
9. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21:167-178.
10. Blaivas JG. Obstructive uropathy in the male. Urol Clin North Am 1996; 23:373-384.
11. Geirsson G, Fall M, Lindström S. Subtypes of overactive bladder in old age. Age Ageing 1993; 22:125-131.
12. Wein AJ, Abrams P (editors). The overactive bladder and its treatments: Consensus Conference. BJU Int 2000; 85 (Suppl 3):1-84.
13. Cumming JA, Chisholm GD. Changes in detrusor innervation with relief of outflow tract obstruction. Br J Urol 1992; 69:7-11.
14. Chapple CR, Smith D. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br J Urol 1994; 73:117-123.
15. Kimche D, Saar M, Lask D. Evoked response studies in detrusor hyperreflexia due to infravesical obstruction in neurological patients. J Urol 1985; 133:641-643.
16. Staskin DS, Vardi Y, Siroky MB. Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control. J Urol 1988; 140:117-118.
17. Kahn Z, Nadelson E, Mieza M, et al. Causes of post-prostatectomy retention. Urology 1991; 37:263-265.
18. Nitti VW. The role of clinical research in the diagnosis and treatment of urinary incontinence. J Urol 1996; 155:1268-1269.
19. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132:474-479.
20. Gosling JA, Kung LS, Doxon JS, et al. Correlation between the structure and function of the rabbit urinary bladder following partial outlet obstruction. J Urol 2000; 163:1349-1356.
21. Fry CH, Wu C. The cellular basis of bladder instability. Br J Urol 1998; 81:1-8.
22. Levin RM, Levin SS, Zhao Y, et al. Cellular and molecular aspects of bladder hypertrophy. Eur Urol 1997; 32 (Suppl 1):15-21.
23. Brading AF. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br J Urol 1994; 74:117-123.
24. Chancellor MB, Rivas DA. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia. J Urol 1993; 150:1706-1708.
25. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 1993; 42:36-40.
26. Sonke GS, Kortmann BB, Verbeek AL, et al. Variability of pressure-flow studies in men with lower urinary tract symptoms. Neurourol Urodyn 2000; 19:637-651.
27. Fitzpatrick JM, Gardiner RA, Worth PH. The evaluation of 68 patients with post-prostatectomy incontinence. Br J Urol 1979; 51:552-555.
28. Akino H, Gobara M, Okada K. Bladder dysfunction in patients with benign prostatic hyperplasia: relevance of cystometry as prognostic indicator of the outcome after prostatectomy. Int J Urol 1996; 3:441-447.
29. Ameda K, Nantani M, Taniguchi K, et al. Preoperative cystometric analysis of benign prostatic hyperplasia - special reference to the natural history and postoperative outcomes. Nippon Hinyokika Gakkai Zasshi 1993; 84:322-329.
30. de Nunzio C, Franco G, Rocchegiani A, et al. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol 2003; 169:535-539.
31. Ogiste JS, Cooper K, Kaplan SA. Are stents still a useful therapy for benign prostatic hyperplasia? Curr Opin Urol 2003; 13:51-57. This is a very nice review of the variety of different devices, including advantages and disadvantages of the different permanent and temporary intraprostatic stents.
32. Kemppainen E, Talja M, Riihela M, et al. A bioresorbable urethral stent. An experimental study. Urol Res 1993; 21:235-238.
33. Törmälä P. Biodegradable self-inforced composite materials; manufacturing structure and mechanical properties. Clin Mater 1992; 10:29-34.
34. Talja M, Tammela T, Petas A, et al. Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomy. J Urol 1995; 154:2089-2092.
35. Dahlstrand C, Grundtman S, Pettersson S. High-energy transurethral microwave thermotherapy for large severely obstructing prostates and the use of biodegradable stents to avoid catheterization after treatment. Br J Urol 1997; 79:907-909.
36. Knutson T, Pettersson S, Dahlstrand C. The use of biodegradable PGA stents to judge the risk of post-TURP incontinence in patients with combined bladder outlet obstruction and overactive bladder. Eur Urol 2002; 42:262-267. This small study described the novel technique of simulating TURP in cases with BOO and severe overactive bladder.
37. Knutson T, Pettersson S, Dahlstrand C. Pressure-flow studies for patient selection in the treatment of symptomatic BPH - a one-year follow-up study. Scand J Urol Nephrol 2001; 35:470-475.
38. Traxer O, Anidjar M, Gaudez F, et al. A new prostatic stent for the treatment of benign prostatic hyperplasia in high-risk patients. Eur Urol 2000; 38:272-278.
39. Cecchi M, Sepich CA, Pagni GL, et al. Prostatic endoprosthesis in the treatment of prostatic obstruction: preliminary experience with the new Trestle model. Chir Ital 1998; 50:37-40.
40. Nissenkorn I. The intraurethral catheter: three years of experience. Eur Urol 1993; 24:27-30.